ICAM1 and posterior uveitis: Our previously published work has demonstrated that ICAM-1 blockade reduces human retinal endothelial transmigration of leukocytes implicated in the initiation of non-infectious posterior uveitis: Th1 cells, Th17 cells and B cells (6, 7).